The Wake Forest Institute for Regenerative Medicine and Oracle Health Sciences have teamed as part of the Innovation Quarter's iQ Healthtech Labs to develop a consortium of industry, government, and academic members that will study novel approaches to establishing the safety of new drugs that are nearing clinical investigation in humans and FDA approval.
from The Medical News https://ift.tt/3g1Lbbz
from The Medical News https://ift.tt/3g1Lbbz
Comments
Post a Comment